Canine cognitive dysfunction syndrome

B. M. Schneider; M. H. Erhard

doi:10.1055/s-0038-1622835

Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere, Table of Contents

Tierarztl Prax Ausg K Kleintiere Heimtiere 2010; 38(02): 113-118
DOI: 10.1055/s-0038-1622835

Für Studium und Praxis

Schattauer GmbH

Kognitives Dysfunktionssyndrom beim Hund

Vorkommen, Diagnose und therapeutische MaßnahmenCanine cognitive dysfunction syndromeprevalence, diagnosis and therapeutic measures

B. M. Schneider

¹Lehrstuhl für Tierschutz, Verhaltenskunde, Tierhygiene und Tierhaltung (Vorstand: Prof. Dr. M. H. Erhard), Veterinärwissenschaftliches Department der Ludwig-Maximilians-Universität München

,

M. H. Erhard

¹Lehrstuhl für Tierschutz, Verhaltenskunde, Tierhygiene und Tierhaltung (Vorstand: Prof. Dr. M. H. Erhard), Veterinärwissenschaftliches Department der Ludwig-Maximilians-Universität München

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Adams B, Chan A, Callahan H, Milgram NW. The canine as a model of human cognitive aging: recent developments. Prog Neuro-Psychopharm Biol Psychiat 2000; 24: 675-692.
2 Araujo JA, Landsberg GM, Milgram NW, Miolo A. Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, ginkgo biloba, vitamin E, and pyridoxine. Can Vet J 2008; 49: 379-385.
3 Azkona G, Garcia-Belenguer S, Chacón G, Rosado b, León M, Palacio J. Prevalence and risk factors of behavioural changes associated with age-related cognitive impairment in geriatric dogs. J Small Anim Pract 2009; 50: 87-91.
4 Bain MJ, Hart BL, Cliff KD, Ruehl WW. Predicting behavioral changes asso -ciated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001; 218: 1792-1795.
5 Borràs D, Ferrer I, Pumarola M. Age-related changes in the brain of the dog. Vet Pathol 1999; 36: 202-211.
6 Campbell S, Trettien A, Kozan B. A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting. Vet Therapeut 2001; 2: 24-39.
7 Carillo M-C. Ivy GO, Milgram NW, Head E, Wu P, Kitani K. Deprenyl increases activity of superoxide dismutase (SOD) in striatum of dog brain. Life Sci 1994; 54: 1483-1489.
8 Chan AD, Nippak PM, Murphey H, Ikeda-Douglas CJ. Muggenburg B, Head E, Cotman CJ, Milgram NW. Visuospatial impairments in aged canines (canis familiaris): the role of cognitive behavioral therapy. Behav Neurosci 2002; 116: 443-454.
9 Cummings BJ, Head E, Afagh AJ, Milgram NW, Cotman CW. β-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996; 66: 11-23.
10 Dodman NH, Seeler DC, Court MH. Aging changes in the geriatric dog and their impact on anesthesia. Comp Cont Educ Pract 1984; 6: 1106-1113.
11 Hagen TM, Liu J, Lykkesfeldt J. Feeding acetyl-L-carnitine and alpha lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci 2002; 99: 1870-1875.
12 Heath SE, Barabas S, Craze PG. Nutritional supplementation in cases of canine cognitive dysfunction – a clinical trial. Appl Anim Behav Sci 2007; 105: 284-296.
13 Landsberg GM, Ruehl WW. Geriatric behavioral problems. Vet Clin North Am Small Anim Pract 1997; 27: 1537-1559.
14 Landsberg G, Araujo JA. Behavior problems in geriatric pets. Vet Clin North Am Small Anim Pract 2005; 35: 675-698.
15 Landsberg G, Hunthausen W, Ackerman L. eds. Handbook of behaviour problems of the dog and cat Oxford: Elsevier Saunders; 2003
16 Liu J, Head E, Gharib AM, Yuan W, Ingersoll RT, Hagen TM, Cotman CW, Ames BN. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc Natl Acad Sci USA 2002; 99: 2356-2361.
17 Lookwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of co-enzyme Q10. Biochem Biophys Res Commun 1994; 119: 1504-1508.
18 Milgram NW, Ivy GO, Head E, Murphy MP, Wu PH, Ruehl WW, Yu PH, Durden DA, Davis BA, Paterson IA, Boulton AA. The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochem Res 1993; 18: 1211-1219.
19 Milgram NW, Ivy GO, Murphy MP, Head EWUPH, Ruehl WW, Yu PH, Durden DA, Davis BA, Boulton AA. Effects of chronic oral administration of L-deprenyl in the dog. Pharmacol Biochem Behav 1995; 51: 421-428.
20 Milgram NW, Zicker SC, Head E, Muggenburg BA, Murphey H, Ikeda-Douglas CJ, Cotman CW. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 2002; 23: 737-745.
21 Milgram NW, Head E, Muggenburg B, Holowachuk D, Murphey H, Estrada J, Ikeda-Douglas CJ, Zicker SC, Cotman CW. Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy. Neurosci Biobehav Rev 2002; 26: 679-695.
22 Milgram NW, Head E, Zicker SC, Ikeda-Douglas C, Murphey H, Muggenburg BA, Siwak CT, Tapp PD, Lowry SR, Cotman CW. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004; 39: 753-765.
23 Milgram NW, Head E, Zicker SC, Ikeda-Douglas CJ, Murphey H, Muggenburg B, Siwak C, Tapp D, Cotman CW. Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. Neurobiol Aging 2005; 26: 77-90.
24 Milgram NW, Araujo JA, Hagen TM, Treadwell BV, Ames BN. Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. FASEB J 2007; 21: 3756-3762.
25 Neilson JC, Hart BL, Cliff KD, Ruehl WW. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001; 18: 1787-1791.
26 Osella MC, Re G, Odore R, Girardi C, Badino P, Barbero R, Bergamasco L. Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007; 105: 297-310.
27 Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S. Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriat Psychiat 2006; 14: 704-715.
28 Pugliese M, Geloso MC, Carrasco JL, Mascort J, Michetti F, Mahy N. Canine cognitive deficit correlates with diffuse plaque maturation and S100β(-)astrocytosis but not with insulin cerebrospinal fluid level. Acta Neuropathol 2006; 111: 519-528.
29 Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ. Memantine in moderate-to-severe Alzheimer’s disease. New Engl J Med 2003; 348: 1333-1341.
30 Rème CA, Dramard V, Kern L, Hofmans J, Halsberghe C, Mombiela DV. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blinded, placebo-controlled trial. Vet Ther 2008; 9: 69-82.
31 Schneider BM, Dodman N H, Maranda L. Use of memantine in treatment of canine compulsive disorders. J Vet Behav 2009; 4: 118-126.
32 Takeuchi T, Harada E. Age-related changes in sleep-wake rhythm in dog. Behav Brain Res 2002; 136: 193-199.